The Administration of Cannabinoid Receptor 2 Agonist Decreases Binge-like Intake of Palatable Food in Mice. [PDF]
Rodríguez-Serrano LM +1 more
europepmc +1 more source
Identification of a Cannabinoid Receptor 2 Allosteric Site Using Computational Modeling and Pharmacological Analysis. [PDF]
Farooq Z +6 more
europepmc +1 more source
Promotion of recovery from Traumatic Brain Injury (TBI) by Granulocyte Colony-Stimulating Factor (G-CSF) treatment requires cannabinoid receptor type 2 activity. [PDF]
Song S +5 more
europepmc +1 more source
The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update. [PDF]
Rakotoarivelo V +4 more
europepmc +1 more source
Elucidating interplay between myrcene and cannabinoid receptor 1 receptors to produce antinociception in mouse models of neuropathic pain. [PDF]
Alayoubi M +7 more
europepmc +1 more source
Related searches:
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists
Biochemical Pharmacology, 2019Cannabinoid receptors type 1 (CB1) and type 2 (CB2) are promising targets for a number of diseases, including obesity, neuropathic pain, and multiple sclerosis, among others. Upon ligand-mediated activation of these receptors, multiple receptor conformations could be stabilized, resulting in a complex pattern of possible intracellular effects. Although
Elise Wouters +3 more
openaire +3 more sources
Cannabinoids, cannabinoid receptors and tinnitus
Hearing Research, 2016One hypothesis suggests that tinnitus is a form of sensory epilepsy, arising partly from neuronal hyperactivity in auditory regions of the brain such as the cochlear nucleus and inferior colliculus. Although there is currently no effective drug treatment for tinnitus, anti-epileptic drugs are used in some cases as a potential treatment option. There is
Paul F, Smith, Yiwen, Zheng
openaire +2 more sources

